InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Knight Peter S. Officer active across 1 company, notably bioAffinity Technologies, Inc.. In total, 5 reports have been recorded. Breakdown: 1 buy · 0 sell. Activity tracked since 1 January 2023. The latest transaction was disclosed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
KNIGHT PETER S is a Director of bioAffinity Technologies, Inc. (XNAS). He has 5 filings in total, and the sampled recent filings cover the period from 2022-12-05 to 2024-07-02, with buy and sell amounts shown as EUR 0 in this sample; the top filings show EUR 17746.74244980405 on 2024-01-24 and EUR 17594.96684700513 on 2023-07-06.